Hyperloop Capital Insights: Eli Lilly Expands Zepbound Access Through Ro Telehealth Partnership
Access Eli Lilly’s weight-loss drug, Zepbound, easier through Ro’s telehealth platform and LillyDirect. This partnership offers a convenient, affordable option for FDA-approved weight management with single-dose vials.